drugset / Trial / NCT01718678
Effect of Melatonin on Multiple Sclerosis Related Fatigue
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study was to evaluate the efficacy and safety of Melatonin in treatment of fatigue and Quality of Life of MS patients.
Timeline
- Start
- 2012-05
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 3 mg | — |
Indications
No indication recorded.